Clinical Trial: Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160790) titled 'Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease' on Aug. 29.

Brief Summary: This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD

Study Start Date: Sept. 02

Study Type: INTERVENTIONAL

Condition: Non-erosive Gastroesophageal Reflux Disease

Intervention: DRUG: JP-1366 + placebo

taking JP-1366 + placebo

DRUG: Placebo + Placebo

taking placebo + placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Onconic Therapeutics Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....